2seventy bio Future Growth
Future criteria checks 1/6
2seventy bio is forecast to grow earnings and revenue by 70.9% and 8.4% per annum respectively. EPS is expected to grow by 71.3% per annum. Return on equity is forecast to be -14% in 3 years.
Key information
70.9%
Earnings growth rate
71.3%
EPS growth rate
| Biotechs earnings growth | 21.3% |
| Revenue growth rate | 8.4% |
| Future return on equity | -14.0% |
| Analyst coverage | Good |
| Last updated | 17 Apr 2024 |
Recent future growth updates
Recent updates
2seventy Bio: Maximizing ABECMA's Potential To Fuel A Turnaround
Apr 03These Analysts Just Made A Massive Downgrade To Their 2seventy bio, Inc. (NASDAQ:TSVT) EPS Forecasts
Mar 07
2seventy bio, Inc. (NASDAQ:TSVT) Held Back By Insufficient Growth Even After Shares Climb 49%
Feb 06Here's Why We're Watching 2seventy bio's (NASDAQ:TSVT) Cash Burn Situation
Jan 172seventy bio, Inc. (NASDAQ:TSVT) Shares Fly 44% But Investors Aren't Buying For Growth
Dec 13Industry Analysts Just Made A Dazzling Upgrade To Their 2seventy bio, Inc. (NASDAQ:TSVT) Revenue Forecasts
May 05Industry Analysts Just Upgraded Their 2seventy bio, Inc. (NASDAQ:TSVT) Revenue Forecasts By 12%
Mar 212seventy bio, Inc. (NASDAQ:TSVT) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates
Mar 19We're Keeping An Eye On 2seventy bio's (NASDAQ:TSVT) Cash Burn Rate
Oct 042seventy Bio: This Spinoff In The CAR-T Space Is Attractive
Sep 082seventy bio Prospects
Aug 23Time To Worry? Analysts Just Downgraded Their 2seventy bio, Inc. (NASDAQ:TSVT) Outlook
Aug 122seventy bio GAAP EPS of -$2.02 misses by $0.09, revenue of $13.48M misses by $3.04M
Aug 10Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 109 | -19 | N/A | N/A | 5 |
| 12/31/2025 | 114 | -33 | N/A | 106 | 8 |
| 12/31/2024 | 88 | -98 | N/A | 8 | 8 |
| 12/31/2023 | 100 | -218 | -181 | -167 | N/A |
| 9/30/2023 | 146 | -184 | -176 | -160 | N/A |
| 6/30/2023 | 147 | -180 | -226 | -199 | N/A |
| 3/31/2023 | 125 | -215 | -238 | -213 | N/A |
| 12/31/2022 | 91 | -254 | -259 | -228 | N/A |
| 9/30/2022 | 51 | -292 | -259 | -238 | N/A |
| 6/30/2022 | 57 | -284 | -237 | -221 | N/A |
| 3/31/2022 | 51 | -291 | -233 | -216 | N/A |
| 12/31/2021 | 55 | -292 | -226 | -207 | N/A |
| 9/30/2021 | 48 | -308 | -229 | -203 | N/A |
| 6/30/2021 | 48 | -320 | -244 | -223 | N/A |
| 3/31/2021 | 150 | -222 | -180 | -157 | N/A |
| 12/31/2020 | 248 | -120 | -90 | -68 | N/A |
| 12/31/2019 | 44 | -321 | -268 | -208 | N/A |
| 12/31/2018 | 55 | -200 | -197 | -146 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TSVT is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: TSVT is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: TSVT is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: TSVT's revenue (8.4% per year) is forecast to grow faster than the US market (8% per year).
High Growth Revenue: TSVT's revenue (8.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: TSVT is forecast to be unprofitable in 3 years.